MindWalk Holdings Corp
Research MindWalk Holdings Corp (HYFT) on Bullrun: market cap USD 65.79M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerHYFT
- ExchangeNASDAQ
- CountryUnited States
- SectorHealthcare
- IndustryBiotechnology
- CurrencyUSD
- Market capUSD 65.79M
- Financial periodFY2026
- RevenueCAD 15.56M
- Revenue growth46.4%
- Net income-CAD 13.95M
- Free cash flow-CAD 12.86M
- Gross margin58.8%
Valuation Snapshot
latest market cap is USD 65.79M.
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2026 | CAD 15.56M | -CAD 13.95M | -CAD 12.86M | 58.8% | -0.31 | CAD 11.35M | CAD 3.53M | CAD 11.75M |
| FY2025 | CAD 10.63M | -CAD 30.23M | -CAD 7.21M | 53.9% | -0.9 | CAD 10.67M | CAD 13.40M | CAD 23.63M |
| FY2024 | CAD 10.28M | -CAD 26.12M | -CAD 4.58M | 39.8% | -1.02 | CAD 3.46M | CAD 13.68M | CAD 35.68M |
| FY2023 | CAD 20.67M | -CAD 26.56M | -CAD 21.33M | 56.0% | -1.07 | CAD 8.28M | CAD 7.27M | CAD 57.80M |
| FY2022 | CAD 19.36M | -CAD 16.71M | -CAD 11.18M | 56.7% | -0.85 | CAD 29.97M | CAD 2.77M | CAD 75.29M |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-12 | USD 65.79M | n/a | n/a | n/a |
| 2025 | 2025-12-31 | USD 84.98M | n/a | n/a | n/a |
| 2024 | 2024-12-31 | USD 12.74M | n/a | n/a | n/a |
| 2023 | 2023-12-29 | USD 45.00M | n/a | n/a | n/a |
| 2022 | 2022-12-30 | USD 129.91M | n/a | n/a | n/a |
| 2021 | 2021-12-31 | USD 104.14M | n/a | n/a | n/a |
About MindWalk Holdings Corp
MindWalk Holdings Corp. operates as a bio-native AI company. The company discovers and develops biologics through HYFT Technology and LensAI platform, as well as develops AI drug discovery and biologics through ReefIQ technology. The company was formerly known as ImmunoPrecise Antibodies Ltd. and changed its name to MindWalk Holdings Corp. in September 2025. The company was incorporated in 1983 and is headquartered in Austin, Texas.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is MindWalk Holdings Corp's market cap?
MindWalk Holdings Corp's market capitalization is USD 65.79M.
What does MindWalk Holdings Corp do?
MindWalk Holdings Corp. operates as a bio-native AI company. The company discovers and develops biologics through HYFT Technology and LensAI platform, as well as develops AI drug discovery and biologics through ReefIQ technology. The company was formerly known as ImmunoPrecise Antibodies Ltd. and changed its name to MindWalk Holdings Corp. in September 2025. The company was incorporated in 1983 and is headquartered in Austin, Texas.